Keene & Associates, Inc. Merck & Co., Inc. Transaction History

Keene & Associates, Inc.

$121 Million
Q2 2024

A detailed history of Keene & Associates, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Keene & Associates, Inc. holds 26,185 shares of MRK stock, worth $3.09 Million. This represents 2.67% of its overall portfolio holdings.

Number of Shares

26,185

Previous 33,390 21.58%

Holding current value

$3.09 Million

Previous $4.41 Million 26.42%

% of portfolio

2.67%

Previous 3.32%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $891,979 - $957,976	-7,205 Reduced 21.58%	26,185 $3.24 Million
Q1 2024 Apr 24, 2024	SELL	$113.24 - $131.95 $113,126 - $131,818	-999 Reduced 2.9%	33,390 $4.41 Million
Q4 2023 Jan 29, 2024	SELL	$100.18 - $109.02 $35,864 - $39,029	-358 Reduced 1.03%	34,389 $3.75 Million
Q3 2023 Oct 13, 2023	BUY	$102.95 - $114.33 $39,326 - $43,674	382 Added 1.11%	34,747 $3.58 Million
Q2 2023 Jul 26, 2023	SELL	$108.61 - $118.38 $5,973 - $6,510	-55 Reduced 0.16%	34,365 $3.97 Million
Q1 2023 Apr 19, 2023	SELL	$102.94 - $114.86 $221,115 - $246,719	-2,148 Reduced 5.87%	34,420 $3.66 Million
Q4 2022 Feb 09, 2023	SELL	$87.44 - $112.11 $438,686 - $562,455	-5,017 Reduced 12.06%	36,568 $4.06 Million
Q3 2022 Nov 01, 2022	SELL	$84.53 - $94.96 $45,223 - $50,803	-535 Reduced 1.27%	41,585 $3.58 Million
Q2 2022 Jul 21, 2022	SELL	$83.49 - $94.64 $13,358 - $15,142	-160 Reduced 0.38%	42,120 $3.84 Million
Q1 2022 Apr 12, 2022	BUY	$73.51 - $82.4 $282,131 - $316,251	3,838 Added 9.98%	42,280 $3.47 Million
Q4 2021 Jan 31, 2022	BUY	$72.28 - $90.54 $2.78 Million - $3.48 Million	38,442 New	38,442 $2.95 Million

Others Institutions Holding MRK

# of Institutions

3,825

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $299B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keene & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Keene & Associates, Inc. with notifications on news.

Account

Keene & Associates, Inc. Merck & Co., Inc. Transaction History